Barclays’s Fractyl Health GUTS Stock Holding History

Barclays’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.48K	Sell	1,865 -114,183	-98%	-$81.3K	﹤0.01%	4900
2026 Q1	$53.1K	Sell	116,048 -127,246	-52%	-$117K	﹤0.01%	4297
2025 Q4	$535K	Buy	+243,294	New	+$392K	﹤0.01%	3807
2025 Q2	–	Sell	-35,907	Closed	-$42.7K	–	5596
2025 Q1	$42.7K	Sell	35,907 -17,019	-32%	-$27.2K	﹤0.01%	4655
2024 Q4	$109K	Buy	52,926 +5,130	+11%	+$11.9K	﹤0.01%	4571
2024 Q3	$121K	Buy	47,796 +45,219	+1,755%	+$148K	﹤0.01%	4519
2024 Q2	$11K	Buy	+2,577	New	+$16.6K	﹤0.01%	4510

Other funds holding GUTS

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Barclays's GUTS Position: Q2 2026 in Review

Barclays reduced its Fractyl Health (GUTS) stake by 98% in Q2 2026, selling an estimated $81.3K and leaving 1,865 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #4900.

Barclays first reported a position in GUTS in Q2 2024 and has held it in 7 quarters since. The position peaked at $535K in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

Barclays held 1,865 shares of Fractyl Health worth $1.48K as of Q2 2026.
Barclays sold 114,183 Fractyl Health shares in Q2 2026, an estimated $81.3K.
Fractyl Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4900 holding.
Barclays first reported a position in Fractyl Health in Q2 2024 and has held it in 7 quarters since.
Barclays's Fractyl Health position peaked at $535K in Q4 2025.
77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.